Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors
Open accessThe DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
Fiber fermentation by gut microbiota yields short-chain fatty acids (SCFAs) that are either absorbed by the gut or excreted in feces. Studies are conflicting as to whether SCFAs are beneficial or detrimental to cardiometabolic health, and how gut microbiota associated with SCFAs is unclear. In this study of 441 community-dwelling adults, we examined associations of fecal SCFAs, gut microbiota diversity and composition, gut permeability, and cardiometabolic outcomes, including obesity and hypertension. We assessed fecal microbiota by 16S rRNA gene sequencing, and SCFA concentrations by gas chromatography/mass spectrometry. Fecal SCFA concentrations were inversely associated with microbiota diversity, and 70 unique microbial taxa were differentially associated with at least one SCFA (acetate, butyrate or propionate). Higher SCFA concentrations were associated with a measure of gut permeability, markers of metabolic dysregulation, obesity and hypertension. Microbial diversity showed association with these outcomes in the opposite direction. Associations were significant after adjusting for measured confounders. In conclusion, higher SCFA excretion was associated with evidence of gut dysbiosis, gut permeability, excess adiposity, and cardiometabolic risk factors. Studies assessing both fecal and circulating SCFAs are needed to test the hypothesis that the association of higher fecal SCFAs with obesity and cardiometabolic dysregulation is due to less efficient SCFA absorption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Million, M., Angelakis, E., Maraninchi, M., Henry, M., Giorgi, R., Valero, R., Vialettes, B., & Raoult, D. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.20 · Cited by 362
RetractedSchloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549 · cited 1×
“36 [22] following its standard operating procedure available November 2015.”
MethodAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“, homozygous for a mutation in the leptin gene (ob/ob) that produces a stereotyped, fully penetrant obesity phenotype) compared to their lean siblings (ob/+ and +/+) have a gut microbiome composition that promotes obesity through excess SCFA production and increased energy availability [14].”
BackgroundStructure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891 · cited 1×
“OTUs delimited at 97% identity were generated and classified using Greengenes 13_8_99 [23].”
MethodA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 1×
“, acetyl/propionyl-CoA carboxylase and acetyl-CoA carboxylase) [17].”
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 1×
“LBP is a biomarker of bacterial-derived LPS translocation from the gut to the periphery and higher serum LBP levels are thought to reflect gut permeability [43] and metabolic endotoxemia [44].”
BackgroundThe Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413 · cited 1×
“SCFAs may also be involved in appetite regulation [9], and play a role in gut and peripheral immune responses [10]; inducing the differentiation of T-regulatory cells [11].”
BackgroundCani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511 · cited 1×
“On the other hand, participants with lower fecal SCFA excretion had a diverse microbiome, enriched in beneficial microbes including Akkermansia muciniphila, a taxon involved in maintaining the integrity of the mucin layer [50]; Christensenellaceae, Methanobrevibacter and Oscillospira, taxa associated with lower BMI [5…”
Background
Research works printed but not linked: 1
- (2017, June 01). IPAQ Research Committee Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ): Short and Long Forms. Available online: http://www.academia.edu/5346814/Guidelines_for_Data_Processing_and_Analysis_of_the_International_Physical_Activity_Questionnaire_IPAQ_Short_and_Long_Forms_Contents.
Cited by
Items 401–500 of 556
Żeber‐Lubecka, N., Kulecka, M., Bałabas, A., Czarnowski, P., Pyśniak, K., Dąbrowska, M., Ostrowski, J., & Hennig, E. E. (2025) · Biology · doi:10.3390/biology14091278 · Cited by 3
“Growing evidence shows that various metabolic disorders, including diabetes and obesity, are associated with changes in the gut microbiome [21–24].”
Zhao, L., Zhao, C., Li, A., Gao, Q., Ai, S., Wang, Y., Chen, Z., & Wang, Z. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1671238 · Cited by 2
Pitts, E., Grainger, B. T., McKenzie, D., & Fiorenza, S. (2025) · Microorganisms · doi:10.3390/microorganisms13102302 · Cited by 3
“These beneficial bacteria promote the fermentation of undigested carbohydrates, synthesising short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate, which have anti-inflammatory effects, and provide defence against pathogens [15].”
Liang, M., Li, L., & Fan, J. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09100-y · Cited by 5
“Concentrations of SCFAs in the gut lumen and systemic circulation are modulated by microbial synthesis efficiency and intestinal mucosal permeability; thus, fecal levels incompletely reflect total SCFA dynamics [141].”
Hane, M., Shimamoto, K., Matsui, R., Shimizu, K., Katto, M., Asahara, T., Shishido, Y., & Kurakawa, T. (2025) · Applied and Environmental Microbiology · doi:10.1128/aem.01836-25 · Cited by 2
Yin, W., Ma, S., Igarashi, M., Li, X., Suzuki-Kemuyama, N., Hasebe, Y., Kato, H., & Jia, H. (2026) · Bioscience Reports · doi:10.1042/bsr20253696 · Cited by 3
“These metabolites play key roles in maintaining epithelial barrier integrity and modulating inflammation [36].”
Hou, X., Guan, X., Qin, X., & Guo, H.-D. (2026) · Chinese Medicine · doi:10.1186/s13020-026-01336-w · Cited by 2
Wang, P., Li, X., Zhang, J., Wang, J., & Jin, L. H. (2026) · Microbiome · doi:10.1186/s40168-026-02356-2 · Cited by 2
“Mounting evidence has established the gut microbiota as a key modulator of host lipid metabolism, particularly through bacterial fermentation-derived metabolites such as SCFAs [31].”
Peterson, R., van der Made, J., Donovan, S. M., Wang, M., Dilger, R. N., Kaplan, N., & Clark, A. J. (2026) · Journal of Dietary Supplements · doi:10.1080/19390211.2026.2673021 · Cited by 3
The Postprandial Chronobiome in Interorgan Glucose Homeostasis
Božić, J., Šantić, R., & Kumrić, M. (2026) · Comprehensive physiology · doi:10.1002/cph4.70236 · Cited by 2
“First, mean SCFA concentrations differ incon-sistently across matrices and phenotypes, whereas the temporal organization of microbial features varies with metabolic state (Reitmeier et al. 2020; Asnicar et al. 2021; Zeevi et al. 2015; Müller et al. 2019; De La Cuesta-Zuluaga et al. 2018).”
Leveraging the Microbiome for Obesity: Moving From Form to Function
Lee, A. H., Manly, A., & Dong, T. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.918923 · Cited by 2
Berberine interacts with gut microbiota and its potential therapy for polycystic ovary syndrome
Zhu, T., & Li, X. (2023) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13814 · Cited by 2
Sleeve Gastrectomy Protects Against Hypertension in Rats due to Changes in the Gut Microbiome
Barron, M., Fernando, D. G., Atkinson, S. N., Kirby, J. R., & Kindel, T. L. (2024) · Journal of Surgical Research · doi:10.1016/j.jss.2024.05.044 · Cited by 2
Knowledge and perceptions of South African blood donors towards biobanking and stool donation
Claassen-Weitz, S., du Toit, E., Gardner‐Lubbe, S., Kullin, B., Bellairs, G., Hilton, C., Chicken, A., Welp, K., Livingstone, H., & Brink, A. J. (2024) · Southern African Journal of Infectious Diseases · doi:10.4102/sajid.v39i1.645 · Cited by 3
Role of the Microbiome in Cardiovascular Disease
Chaikijurajai, T., Wilcox, J. D., & Tang, W. H. W. (2021) · Contemporary cardiology · doi:10.1007/978-3-030-78177-4_15 · Cited by 2
Li, Y., Jiang, J., Zhu, L., Wang, X., Wan, W., Wang, D., & Li, Z. (2022) · Microorganisms · doi:10.3390/microorganisms10071453 · Cited by 2
Toshida, K., Itoh, S., Kosai‐Fujimoto, Y., Ishikawa, T., Nakayama, Y., Tsutsui, Y., Iseda, N., Izumi, T., Bekki, Y., Yoshiya, S., et al. (2023) · JGH Open · doi:10.1002/jgh3.13018 · Cited by 2
“17 SCFAs modulate endothelial function, immune responses, and vascular tone.”
BackgroundSerrano, J., Smith, K. R., Crouch, A. L., Sharma, V., Yi, F., Vargová, V., LaMoia, T. E., Dupont, L. M., Serna, V. A., Tang, F., et al. (2020) · doi:10.21203/rs.2.23608/v1 · Cited by 2
Influence of gut microbiota on the development of insulin resistance
Demidova, T. Y., Геннадьевна, Л. К., Shevtsova, N. S., Korotkova, T. N., & Kochina, A. S. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-10-84-95 · Cited by 2
PREDICTION OF VITAMINS AND SHORT-CHAIN FATTY ACIDS SYNTHESIS PATHWAYS IN OBESE ADULTS
Shestopalov, A. V., Ganenko, L. A., Kolesnikova, I. M., Grigoryeva, T. V., Vasilyev, I. Y., Naboka, Y. L., Волкова, Н. И., Borisenko, O. V., & Roumiantsev, S. A. (2023) · Журнал эволюционной биохимии и физиологии · doi:10.31857/s0044452923050078 · Cited by 1
Metabolic activity of the colon microbiota in patients with obesity (pilot research)
Сергеевна, Д. Т., Суплотова, Л. А., Михайлович, К. С., & Fedoseeva, N. N. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-136 · Cited by 1
Vineetha, K. K., Archana, P. R., Rao, B. K., Ballal, M., Dutta, B., Vani Lakshmi, R., & Bhat, R. G. (2024) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.9923 · Cited by 1
Sim, D.-H., Lee, D.-H., Lee, J., & Hong, K. (2024) · Exercise Science · doi:10.15857/ksep.2024.00577 · Cited by 1
Du, Q., Fu, R., Zhao, M., & Xu, M. (2025) · Foods · doi:10.3390/foods14152557 · Cited by 5
Ray, M., Ashwini, M., Bhargava, N., & Mondal, K. C. (2025) · Springer eBooks · doi:10.1007/978-3-031-94472-7_14 · Cited by 1
Plata, A. A., Otmanowski, E., & Zubcevic, J. A. (2025) · Microbiota and Host · doi:10.1530/mah-25-0008 · Cited by 2
Characterization of the Fecal Metabolome in Patients With Early Systemic Sclerosis
Young, A., Andréasson, K., Labus, J. S., Matulionis, N., Jacobs, J. P., Christofk, H. R., & Volkmann, E. R. (2025) · ACR Open Rheumatology · doi:10.1002/acr2.70127 · Cited by 1
Akhtara, N., & Bharali, M. K. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.111939 · Cited by 1
Hu, J., ChangChang, C. A. O., Sengers, M. J., Xie, X. P., Cheng, T., Rahman, M., Li, Y., Li, P., Chen, X., Qi, X., et al. (2026) · Poultry Science · doi:10.1016/j.psj.2026.106530 · Cited by 1
“Nonetheless, certain studies indicated that elevated SCFA concentrations may be correlated with diminished gut microbial diversity, increased intestinal permeability, and markers indicative of metabolic dysfunction (de la Cuesta-Zuluaga et al., 2018; Lau and Vaziri, 2019; Sanna et al., 2019).”
Rodrigue, A. F., Pereira, B. B., Freije, G., Sweet, A., Mahmoudian, L., Aly, M., Mahmoodianfard, S., Kishore, L., Audet, M., Minicucci, M. F., et al. (2026) · Nutrients · doi:10.3390/nu18030461 · Cited by 1
Ren, J., Perhat, S. H., Gao, M., Hao, C., Malipati-Nuertai, & Li, Y. (2026) · Fitoterapia · doi:10.1016/j.fitote.2026.107203 · Cited by 1
Khan, I. M., Khan, S. U., Nassar, N., Khan, S., Shafiq, M., Saadeldin, I. M., Swelum, A. A., Cheng, M., & Wang, Z. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-026-00999-5 · Cited by 1
“Individuals with GM dysbiosis may beunable toabsorbsuf fi cient calcium andvitamin D, which may lead to reduced bone density, osteomalacia, and other related symptoms 82,83 .”
Metabolic Screening of Gut Microbiota by Fourier-Transform Infrared Spectroscopy
Sayol-Altarriba, A., Aira, A., Martín-López, E., Villasante, A., Albarracín, R., Faneca, J., Pitart, C., Roca, I., Casals, G., Marco, S., et al. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6c00128 · Cited by 1
Reshaping of the fecal proteome and metaproteome in obese patients 2 years after bariatric surgery
Tanca, A., Diego, L. D., Deledda, M. A., Maio, F. D., Boru, C. E., Musella, M., Raffaelli, M., Silecchia, G., Delogu, G., & Uzzau, S. (2026) · mSystems · doi:10.1128/msystems.01764-25 · Cited by 1
Chen, K., Jia, L., Zhang, Y., Liu, Y., Yang, X. L., & Yang, X. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1811654 · Cited by 1
Acierno, C., Caturano, A., Barletta, F., Rinaldi, L., Sasso, F. C., Adinolfi, L. E., & Nevola, R. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1881697 · Cited by 2
Le, Q. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1902756 · Cited by 1
“…tissue exposure; elevated fecal SCFA levels observed in some obese cohorts do not necessarily re fl ect increased colonic production, but may instead indicate impaired gut absorption, altered colonic transit time, or reduced mucosal utilization (De la Cuesta-Zuluaga et al., 2018; Yu et al., 2025).”
Ramdika, S. B., Mahati, E., Legowo, A. M., Muniroh, M., Nindita, Y., & Afifah, D. N. (2020) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2020v12i11.39209 · Cited by 1
“The total SCFA is the amount of acetate, propionate, and butyrate [29].”
BackgroundNabil, L. M., Sallam, M. M., Mohamed, D. A.-W., Roushdy, M. M. S., Abdelsalam, H. M. A., & Sallam, R. M. (2022) · Obesity Medicine · doi:10.1016/j.obmed.2022.100432 · Cited by 1
Harris, M. D. (2022) · Online Journal of Complementary & Alternative Medicine · doi:10.33552/ojcam.2022.07.000661 · Cited by 2
Pinatih, K. J. P., Wihandani, D. M., Darwinata, A. E., Narayana, G. S., Saputra, I. P. G. S., & Supadmanaba, I. G. P. (2023) · Indonesia Journal of Biomedical Science · doi:10.15562/ijbs.v17i1.457 · Cited by 1
The Gut Microbiome, a Possible Key to Multidisciplinary Clinical Practice - Literature Review
Șchiopu, C. G., Gavril, R. S., Ștefănescu, C., Eşanu, I., & Mitu, F. (2023) · Internal Medicine · doi:10.2478/inmed-2023-0246 · Cited by 1
Tauriainen, M., Csader, S., Lankinen, M. A., Lo, E. K. K., Chen, C., Lahtinen, O., El-Nezami, H. S., Laakso, M., & Schwab, U. (2024) · Nutrients · doi:10.3390/nu16020261 · Cited by 1
“On the other hand, high f-SCFA levels have been found to be associated with gut dysbiosis, excess adiposity, cardiometabolic risk factors [27] and NAFLD [26,28].”
BackgroundMethodWIDE RESECTION IN SACRAL OSTEOBLASTOMA: CASE SERIES
Çakar, A., Tekin, S. B., Aktaş, M. A., Çirçi, E., Polat, B., Peker, B., & Atıcı, Y. (2024) · Journal of Turkish Spinal Surgery · doi:10.4274/jtss.galenos.2024.08769 · Cited by 1
Donatini, B., & Le Blaye, I. (2021) · Journal of Clinical Case Studies · doi:10.16966/2471-4925.216 · Cited by 1
Microbiota and diet in infants and young children
Leong, C. S.-F. (2019) · Otago University Research Archive (University of Otago) · Cited by 2
Effect of frozen-thawed embryo transfer on metabolism of children in early childhoodPreprint
Dong, Z.-H., Wu, T., Feng, T., Zhang, C., Wang, Y., Liu, H., Qin, N., Wang, Y., Xu, J.-J., Li, H., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1625041/v1 · Cited by 1
Masked hypertension in irritable bowel syndrome: A cause for concern?
Wander, G. S., & Batta, A. (2025) · Indian Journal of Gastroenterology · doi:10.1007/s12664-025-01791-7 · Cited by 1
“In an independent observation by De la Cuesta-Zuluaga et al. [15], higher fecal SCFA concentrations were a strong marker of metabolic dysregulation and hypertension.”
Ke, A. (2022) · The Atrium (University of Guelph) · doi:10.3389/fmicb.2021.755083
Bezan, P. N. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-05082019-114853 · Cited by 1
Will Residual Antibiotics in Hen Eggs Elicit Health Risks by Impairing Human Intestinal Microbiome?
wei, Y. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.20.003396
Impact of White and Dark Red Kidney Beans on Intestinal and Metabolic Health in C57Bl/6 Male Mice
Rodrigue, A. F. (2019) · uO Research (University of Ottawa) · doi:10.20381/ruor-24172 · Cited by 1
Short-chain fatty acids: role in metabolic disorders
Fadieienko, G. D., & Gridnyev, O. (2021) · Modern Gastroenterology · doi:10.30978/mg-2021-2-55
Adnan, M. (2021) · New Zealand Medical Student Journal · doi:10.57129/lpyo1716
Galena, A. E. (2021) · University of North Florida Digital Commons (University of North Florida)
Fecal markers in Multiple Sclerosis Sex makes the differencePreprint
Becker, A., Abuazab, M., Schwiertz, A., Walter, S., Fassbender, K. C., Fousse, M., & Unger, M. M. (2020) · doi:10.21203/rs.3.rs-41141/v1
“anorexia (29), obesity, diabetes and as a marker of risk for cardiometabolic disease (30).”
BackgroundGut microbiota and hypertension, diabetes, and other cardiovascular risk factors
Duttaroy, A. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822405-2.00018-9
Kung, S. (2021) · Digital Commons - USU (Utah State University) · doi:10.26076/3060-3b7e
Comprehensive Gut Microbiota and Drug Processing
Selber‐Hnatiw, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00104-2
Atherosclerotic Cardiovascular Disease –The Gut Microbiome as a Risk Factor
Gedda, K. J. (2020) · Scholarly Commons (University of the Pacific)
Drall, K. M. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-zdfs-4k55
Impact of gut-derived metabollites on substrate metabolism and metabolic health
Gonzalez Hernandez Manuel, A. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20201027mgh
Smith, C. A., Haute, M. J. S. V., Xian, Y., Muñoz, R. R. S., Schmaltz, R. J., Ramer‐Tait, A. E., & Rose, D. J. (2022) · Research Square · doi:10.21203/rs.3.rs-1486829/v2
Effect of frozen-thawed embryo transfer on metabolism of children in early childhoodPreprint
Dong, Z.-H., Wu, T., Feng, T., Zhang, C., Wang, Y., Liu, H., Qin, N., Wang, Y., Xu, J., Li, H., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1625041/v2
Smith, C. A., Haute, M. J. S. V., Xian, Y., Muñoz, R. R. S., Schmaltz, R. J., Ramer‐Tait, A. E., & Rose, D. J. (2022) · Research Square · doi:10.21203/rs.3.rs-1486829/v1
Kardiyovasküler Hastalıklarda Bağırsak Metabolitlerinin Rolü
Altun, H., & Çapar, A. G. (2022) · Journal of Nutrition and Dietetics · doi:10.33076/2022.bdd.1636
Porras, D. (2021) · Buleria (Universidad de León) · doi:10.18002/10612/13641
Wang, K., jiang, Y., Chen, T., & Zhou, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-2300873/v1
Kardiyovasküler hastalıklarda bağırsak mikrobiyotasının rolü
Kökcü, E., Akil, Ü., & Asil, E. (2022) · Toros University Journal of Food Nutrition and Gastronomy · doi:10.58625/jfng-1934
The gut microbiota: A driver of Type 2 diabetes
Scheithauer, T. P. M. (2023) · doi:10.5463/thesis.82
Gilbert, J. A., Ecklu-Mensah, G., Maseng, M. G., Donato, S., Choo-Kang, C., Dugas, L. R., Bovet, P., Bedu-Addo, K., Plange‐Rhule, J., Forrester, T., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2791107/v1
Dąbek, A., Kaczmarczyk, O., Dziubyna, T., Piątek-Guziewicz, A., & Zwolinska-Wcislo, M. M. (2023) · Folia Medica Cracoviensia · doi:10.24425/fmc.2023.145912 · Cited by 3
Njemanze, P. C., Amadi, A., Onuchukwu, J. E., Darlington, C. C., Ukeje, N. E., Mezu, C. O., Ofoegbu, C. C., Okuh, C., Ukaegbu, C. O., Uzoma, L. O., et al. (2023) · Preprints.org · doi:10.20944/preprints202307.0106.v1
Shestopalov, A. V., Ganenko, L. A., Kolesnikova, I. M., Grigoryeva, T. V., Vasilyev, I. Y., Naboka, Y. L., Волкова, Н. И., Borisenko, O. V., & Roumiantsev, S. A. (2023) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093023050058
Njemanze, P. C., Amadi, A., Onuchukwu, J. E., Darlington, C. C., Ukeje, N. E., Mezu, C. O., Ofoegbu, C. C., Okuh, C., Ukaegbu, C. O., Uzoma, L. O., et al. (2024) · Qeios · doi:10.32388/y76cza
“Several cross-sectional studies in humans have shown an association between the intestinal microbiome and hypertension [15][16][17][18][19][20][21][22][23][24] .”
BackgroundRodríguez-García, A., Arroyo, A., García-Vicente, R., Morales, M. L., Gómez-Gordo, R., Justo, P., Cuéllar, C., Sánchez‐Pina, J. M., López‐Muñoz, N., Alonso, R., et al. (2024) · doi:10.1158/1078-0432.c.7077687
黄, 琪. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1451426
Pervishko, O. V., Ardatskaya, M. D., Zakharova, I. N., Soboleva, N. G., Stinskaya, U. A., Berezhnaya, I. V., Николаевна, Б. С., & Кирилловна, Д. Д. (2024) · Pediatrics Consilium Medicum · doi:10.26442/26586630.2024.1.202778
Príncipe, L. D. A. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2024.tde-16052024-134808
Plant-Based Diets and Hypertension
Dupuis, L., & Joshi, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-63083-5_27
Human microbiome, obesity and cardiovascular diseases
Piansay‐Soriano, M. E., Soriano, S. K., Pague, B. V., Platero, M. S., Candelario-Plata, M. A., & Calunsag, M. K. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15435-5.00008-6
Hypertension, obesity, and the microbiome in cardiovascular disease
Gupta, A., & Vakilna, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18979-1.00006-x · Cited by 1
Rôle de la dysbiose du microbiote intestinal dans les maladies métaboliques
Auger, S., & Chatel, J. (2025) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2025.01.003
The Critical Role of Gut Microbiota and its Association with Obesity and Related Diseases
(2024) · Obesity and Diabetes Research · doi:10.47275/2692-0964-130
“Through binding to cellular receptors, including TGR5, secondary bile acids reduce macrophage inflammation and lipoprotein uptake, reducing the development of atherosclerosis plaques [39].”
Yasheng, P., Chen, X., Shi, T., Kou, Y., Wang, L., Gao, F., & Yue, H. (2025) · Research Square · doi:10.21203/rs.3.rs-6125489/v1
Dietary Index for Gut Microbiota is negatively associated with HypertensionPreprint
Fu, Y., Peng, M., Cai, H., Zhang, Y., Zheng, Y., & Li, B. (2025) · Research Square · doi:10.21203/rs.3.rs-6437987/v1
Jiang, S., Cai, C., Deehan, E. C., Chen, J., Feng, C., Yang, M., Weng, Z., Long, J., Xie, J., Lin, S., et al. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116866 · Cited by 3
Advances in Microbiome Sequencing Technologies for Studying Gut Health in Metabolic Syndrome
Ramos, E. D. S. F., Couto, R. D. S., & Leal, E. D. S. (2025) · Springer eBooks · doi:10.1007/978-981-96-6246-3_11
Khanna, D., Gopalan, H. S., Abirami, K., Sudha, V., Navilebasappa, A., Kallapura, G., Gayatri, R., Jeevan, R. G., Jayaraman, S., Anjana, R. M., et al. (2025) · Food and Nutrition Sciences · doi:10.4236/fns.2025.168056
Xie, J., Guan, H., Liu, M., & Ding, W. (2025) · PLoS ONE · doi:10.1371/journal.pone.0332038
“Notably, beneficial bacteria within this system can produce and metabolize SMs such as vitamins and short-chain fatty acids, which play vital roles in obesity regulation [15].”
Potential Modulation of Gut Microbiota by Phytochemicals in Managing Noncommunicable Diseases
Nawawi, R. A. (2025) · Biomedical Journal of Indonesia · doi:10.32539/bji.v11i3.250
代, 素. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1482320
Ендокринопатії та їх зв’язок з мікробіотою кишки
Moskva, K. A. (2025) · Primedia eLaunch LLC eBooks · doi:10.36074/ezmk.textbook-2025
Endocrinopathies and their connection with the gut microbiota
Moskva, K. A. (2025) · Primedia eLaunch LLC eBooks · doi:10.36074/ecgm.textbook-2025
Nutritional significance of short-chain fatty acids
Karadağ, M. G., Tuğ, T. A., Ağagündüz, D., & Özoğul, F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33296-8.00005-8
Zhu, W., Edirisuriya, P., Ai, Q., Yang, F., Tang, J., Nie, K., Ji, X., Soltanieh, S., Musarrat, M., Alim, M. A., et al. (2025) · Nutrients · doi:10.3390/nu17243848
Differding, M. K., Benjamin‐Neelon, S. E., Hoyo, C., Østbye, T., & Mueller, N. T. (2020) · Figshare · doi:10.6084/m9.figshare.11972802
Self-citationDifferding, M. K., Benjamin‐Neelon, S. E., Hoyo, C., Østbye, T., & Mueller, N. T. (2020) · Figshare · doi:10.6084/m9.figshare.11972769
Self-citationDifferding, M. K., Benjamin‐Neelon, S. E., Hoyo, C., Østbye, T., & Mueller, N. T. (2020) · Figshare · doi:10.6084/m9.figshare.11972796
Self-citation
Metadata
- Authors
- De la Cuesta-Zuluaga, J., Mueller, N., Álvarez-Quintero, R., Velásquez-Mejía, E., Sierra, J., Corrales-Agudelo, V., Carmona, J., Abad, J., & Escobar, J.
- Affiliations
- Vidarium–Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Calle 8 sur #50-67, 050023 Medellin, Colombia
- Johns Hopkins University (US)
- Grupo de Investigación en Sustancias Bioactivas, Sede de Investigación Universitaria (SIU), Universidad de Antioquia, Calle 62 #52-59, 050010 Medellin, Colombia
- Vidarium - Centro de Investigación en Nutrición Salud y Bienestar (CO)
- Dinámica IPS, Especialista en Ayudas Diagnósticas, Calle 27 #45-109, 050021 Medellin, Colombia
- EPS SURA, Calle 49A #63-55, 050034 Medellin, Colombia
- Corresponding author
- Escobar, Juan
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2018-12-27
- Volume
- 11
- Issue
- 1
- Pages
- 51
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6356834
- OpenAlex
- W2908425894
- Semantic Scholar
- 5eb68bb6bfbbdde0888adeae7373bb6a65842f51
- Cited by
- 533
- References
- 55
- Citations by year
- 2026: 43 · 2025: 61 · 2024: 85 · 2023: 82 · 2022: 81 · 2021: 91 · 2020: 58 · 2019: 31
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Heart, Lung, and Blood Institute (K01HL141589)
- Mid-Atlantic Nutrition Obesity Research Center (P30DK072488)
- Foundation for Gender Specific Medicine (NA)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- short-chain fatty acids, fecal SCFA, gut dysbiosis, microbiome diversity, intestinal permeability, obesity, hypertension, cardiometabolic risk factors, dietary fiber fermentation, acetate, butyrate, propionate
- MeSH terms
- Gastrointestinal Microbiome, Adolescent, Adult, Cardiovascular Diseases, Fatty Acids, Volatile, Feces, Female, Humans, Hypertension, Male, Metabolic Diseases, Middle Aged, Obesity, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.